Development after pediatric brain tumor-a longitudinal study

Research output: Contribution to journalArticle

Standard

Development after pediatric brain tumor-a longitudinal study. / Olsson, Ingrid Tonning; Lundgren, Johan; Hjorth, Lars; Perrin, Sean.

In: Neuro-Oncology, Vol. 18, 01.06.2016, p. 135.

Research output: Contribution to journalArticle

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - Development after pediatric brain tumor-a longitudinal study

AU - Olsson, Ingrid Tonning

AU - Lundgren, Johan

AU - Hjorth, Lars

AU - Perrin, Sean

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background: Patients treated for Pediatric Brain Tumors (PBTs) often experience a decline/stagnation in their cognitive functioning.Anumber of potential risk factors for cognitive decline have been identified including gender (female), young age-at-diagnosis, higher baseline IQ, hydrocephalus at diagnosis, treatment with Whole Brain Radiation Therapy (WBRT), and larger radiation field and/or dose. The aim of this longitudinal study was to statistically model the rate of cognitive decline in a large population-based sample of PBT survivors and to find risk factors for a faster decline. Methods: Study participants were patients diagnosed with PBTs between 2001-2013 and/or who turned 18 years of age between 2006 and 2013 (n = 151). Measures of verbal ability, perceptual reasoning, general cognitive ability, auditory working memory, cognitive processing speed, visual workingmemory and sustained attention were collected longitudinally. Multilevel Linear Modelling (MLM) was used to evaluate the rate of cognitive decline in the sample and to estimate baseline values (risk factors) influencing the rate of decline. Results: A significant decline was found for most cognitive abilities across all patient categories with only elementary verbal skills either stable or improving. Variables predicting lower cognitive performance at baseline were gender (male), age at diagnosis, supratentorial lateral tumor, larger tumor size, and treatment withWBRTor chemotherapy.Conclusions: Pediatric BT survivors experience a decline in age related cognitive performance, regardless of the treatment received. Young age at PBT diagnosis, male, gender, supratentorial lateral tumors, larger tumors and treatment with WBRT or chemotherapy were all correlated with a lowered baseline performance.

AB - Background: Patients treated for Pediatric Brain Tumors (PBTs) often experience a decline/stagnation in their cognitive functioning.Anumber of potential risk factors for cognitive decline have been identified including gender (female), young age-at-diagnosis, higher baseline IQ, hydrocephalus at diagnosis, treatment with Whole Brain Radiation Therapy (WBRT), and larger radiation field and/or dose. The aim of this longitudinal study was to statistically model the rate of cognitive decline in a large population-based sample of PBT survivors and to find risk factors for a faster decline. Methods: Study participants were patients diagnosed with PBTs between 2001-2013 and/or who turned 18 years of age between 2006 and 2013 (n = 151). Measures of verbal ability, perceptual reasoning, general cognitive ability, auditory working memory, cognitive processing speed, visual workingmemory and sustained attention were collected longitudinally. Multilevel Linear Modelling (MLM) was used to evaluate the rate of cognitive decline in the sample and to estimate baseline values (risk factors) influencing the rate of decline. Results: A significant decline was found for most cognitive abilities across all patient categories with only elementary verbal skills either stable or improving. Variables predicting lower cognitive performance at baseline were gender (male), age at diagnosis, supratentorial lateral tumor, larger tumor size, and treatment withWBRTor chemotherapy.Conclusions: Pediatric BT survivors experience a decline in age related cognitive performance, regardless of the treatment received. Young age at PBT diagnosis, male, gender, supratentorial lateral tumors, larger tumors and treatment with WBRT or chemotherapy were all correlated with a lowered baseline performance.

KW - adult

KW - animal model

KW - attention

KW - brain radiation

KW - brain tumor

KW - cancer epidemiology

KW - chemotherapy

KW - child

KW - cognitive defect

KW - controlled study

KW - diagnosis

KW - disease model

KW - drug therapy

KW - female

KW - gender

KW - human

KW - human tissue

KW - longitudinal study

KW - major clinical study

KW - male

KW - population model

KW - risk factor

KW - skill

KW - statistical model

KW - survivor

KW - tumor volume

KW - velocity

KW - working memory

KW - young adult

U2 - 10.1093/neuonc/now079.04

DO - 10.1093/neuonc/now079.04

M3 - Article

VL - 18

SP - 135

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1523-5866

ER -